Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Leukemia risk factor ARID5B coordinates HDAC-mediated transcriptional repression.

Created on 22 Jun 2026

Authors

Ana P Kutschat, Fabian Frommelt, Brianda L Santini, Sophie Müller, Paul Batty, Animesh Awasthi, Gerlinde Karbon, Giulio Superti-Furga, Davide Seruggia

Published in

Nucleic acids research. Volume 54. Issue 12. Jun 22, 2026.

Abstract

Multiple genetic association studies linked variants at ARID5B with predisposition to B-cell-derived acute lymphoblastic leukemia (B-ALL) in children. Still, the molecular function of ARID5B remains largely uncharacterized. Here, we employ a combination of proteomics, genomics, and transcriptomics to describe the molecular mechanisms of ARID5B. We identify that ARID5B interacts with MIER1, C16ORF87, HDAC1, and HDAC2 forming a chromatin repressor complex. By CUT&RUN, we mapped ARID5B binding in active regions of the genome, tethering HDAC1 and HDAC2 to distal regulatory elements and promoters. Genes actively repressed by the ARID5B repressor complex are involved in B-cell proliferation and B-cell-specific signaling. Together, we describe how ARID5B assembles into a repressor complex and regulates B-cell-specific processes. Understanding its molecular mechanism will help elucidating how noncoding germline variants at ARID5B predispose to B-ALL.

PMID:
42328790
Bibliographic data and abstract were imported from PubMed on 22 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement